Cardiol Therapeutics (CRDL) Return on Equity [ROE] (2021 - 2026)
Cardiol Therapeutics (CRDL) recorded Return on Equity [ROE] of -145.44% in Q2 2026, up 126.56 percentage points from -272.00% a year earlier and up 20.52 percentage points from the prior quarter.
Cardiol Therapeutics (CRDL) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Cardiol Therapeutics reported Return on Equity [ROE] of -156.88%, down 18.83 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for three straight years, with a four-year change of -85.51 percentage points (FY2021 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -138.05% in FY2024 (-68.26 pp), -69.80% in FY2023 (-23.90 pp), -45.90% in FY2022 (+25.48 pp) and -71.38% in FY2021.
- The Q2 2026 figure is the highest quarterly Return on Equity [ROE] since Q1 2024.
- On a year-over-year basis, Return on Equity [ROE] rose in two of the last eight quarters, with an average year-over-year change of -53.46 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 126.56 percentage points in Q2 2026, against a drop of 210.44 percentage points in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -165.96% (Q1 2026), -243.36% (Q4 2025) and -327.76% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | - |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 4.97% |
| 10 | Cardiol Therapeutics | 96.99 Mn | 34.78 Mn | - | -148.54% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -148.54% |
| Mar 31, 2026 | -166.16% |
| Dec 31, 2025 | -241.43% |
| Jun 30, 2024 | -171.23% |
| Mar 31, 2024 | -117.00% |
| Dec 31, 2023 | -31.41% |
| Sep 30, 2023 | -19.24% |
| Jun 30, 2023 | -23.36% |
| Mar 31, 2023 | -38.67% |
| Dec 31, 2022 | -42.30% |
| Sep 30, 2022 | -44.77% |
| Jun 30, 2022 | -63.66% |
| Mar 31, 2022 | -54.29% |
| Dec 31, 2021 | -47.14% |
| Sep 30, 2021 | -39.73% |
| Jun 30, 2021 | -36.23% |
Cardiol Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRDL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CRDL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRDL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();